Generate Biomedicines
Clinical trials sponsored by Generate Biomedicines, explained in plain language.
-
New asthma and COPD drug enters first human safety trials
Symptom relief OngoingThis early-stage study tests a new drug called GB-0895 in adults with mild to moderate asthma or COPD. The main goal is to check if the drug is safe and how the body handles it. About 156 participants will receive either the drug or a placebo. This research is a first step to see…
Phase: PHASE1 • Sponsor: Generate Biomedicines • Aim: Symptom relief
Last updated May 17, 2026 07:03 UTC
-
New eczema drug candidate tested in healthy people for first time
Knowledge-focused OngoingThis early-stage study tests a new medicine called GB-7624 in 40 healthy adults to see if it is safe and how the body processes it. The study has two parts: one group gets a single dose, and another gets two doses over two weeks. This research is a first step toward possibly trea…
Phase: PHASE1 • Sponsor: Generate Biomedicines • Aim: Knowledge-focused
Last updated May 17, 2026 06:51 UTC